Forward Citations = 34

Loading Chart...

4 inventors (with patents filed for the assignee):

Alfred M Ajami (4 out of 8 patents)

David O Barlow (2 out of 2 patents)

Mitchell P Fink (1 out of 15 patents)

4. Carrie A Sims (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 6989390 - Amonafide salts (2006-01-24),

2. 6846842 - Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion (2005-01-25),

3. 6693198 - Amonafide salts (2004-02-17),

4. 6610270 - In vivo determination of metabolic function for use in therapy management (2003-08-26),

Xanthus Life Sciences, Inc. is a leading biotechnology company specializing in the discovery and development of innovative therapies for various diseases. With a focus on precision medicine, Xanthus is dedicated to improving patient outcomes through cutting-edge research and personalized treatment options. Our team of experts is committed to advancing healthcare through groundbreaking science and transformative technologies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

4 Patents

#376 in Cambridge, MA

#3,231 in Massachusetts

#58,967 in US

Cambridge, MA, United States of America

Xanthus Life Sciences, Inc.

Forward Citations = 34

4 inventors:

Alfred M Ajami (4 out of 8 patents)

David O Barlow (2 out of 2 patents)

Mitchell P Fink (1 out of 15 patents)

4. Carrie A Sims (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com